World's Best Scientists 2026 revealed!
Bradley C. Leibovich

Bradley C. Leibovich

D-Index & Metrics

Medicine

D-Index
112
Citations
43116
World Ranking
5169
National Ranking
2796

Overview

Bradley C. Leibovich is affiliated with the Mayo Clinic in the United States and has contributed extensively to the field of medicine, with a focus on oncology and urology. Their research encompasses a broad range of topics related to renal and urothelial cancers, cancer immunotherapy, molecular biology, and surgical treatment approaches.

Leibovich's main areas of study include:

  • Medicine

Their subfields of specialization highlight:

  • Pulmonary and Respiratory Medicine
  • Surgery
  • Molecular Biology
  • Oncology
  • Cancer Research

Key research topics covered by their publications involve:

  • Renal cell carcinoma treatment
  • Renal and related cancers
  • Bladder and Urothelial Cancer Treatments
  • Cancer Immunotherapy and Biomarkers
  • Cancer Genomics and Diagnostics
  • Urological Disorders and Treatments
  • Renal and Vascular Pathologies

Bradley C. Leibovich has co-authored frequently with several researchers, including:

  • Stephen A. Boorjian
  • John C. Cheville
  • Christine M. Lohse
  • R. Houston Thompson
  • Brian A. Costello

The scientist's work has been published in a variety of venues, with concentrated contributions to:

  • The Journal of Urology
  • Human Pathology
  • Journal of Clinical Oncology
  • Urologic Oncology Seminars and Original Investigations
  • Urology

Selected recent papers by Bradley C. Leibovich include:

  • Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 Encephalitis, 2020, JAMA Neurology
  • Prospective evaluation of smartwatch-enabled detection of left ventricular dysfunction, 2022, Nature Medicine
  • Low-Grade Oncocytic Tumor of Kidney (CK7-Positive, CD117-Negative): Incidence in a single institutional experience with clinicopathological and molecular characteristics, 2021, Human Pathology
  • Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study, 2024, The Lancet Oncology
  • Leucine Zipper 4 Autoantibody: A Novel Germ Cell Tumor and Paraneoplastic Biomarker, 2021, Annals of Neurology

Best Publications

  • Renal Mass and Localized Renal Cancer: AUA Guideline

    Steven C Campbell;Robert G Uzzo;Mohamad E Allaf;Eric B Bass

  • Costimulatory b7-h1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target

    Lieping Chen;Scott E. Strome;Eugene D. Kwon

  • Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.

    R. Houston Thompson;Susan M. Kuntz;Bradley C. Leibovich;Haidong Dong

  • Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.

    Bradley C. Leibovich;Michael L. Blute;John C. Cheville;M B S Christine Lohse

  • Every Minute Counts When the Renal Hilum Is Clamped During Partial Nephrectomy

    R. Houston Thompson;Brian R. Lane;Christine M. Lohse;Bradley C. Leibovich

  • Radical Nephrectomy for pT1a Renal Masses May be Associated With Decreased Overall Survival Compared With Partial Nephrectomy

    R. Houston Thompson;Stephen A. Boorjian;Christine M. Lohse;Bradley C. Leibovich

  • Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: Implications for prognosis and therapy

    Matthew H.T. Bui;David Seligson;Ken ryu Han;Allan J. Pantuck

  • Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy

    Bradley C. Leibovich;Michael L. Blute;John C. Cheville;Christine M. Lohse

  • The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus

    Michael L. Blute;Bradley C. Leibovich;Christine M. Lohse;John C. Cheville

  • PD-1 Is Expressed by Tumor-Infiltrating Immune Cells and Is Associated with Poor Outcome for Patients with Renal Cell Carcinoma

    R. Houston Thompson;Haidong Dong;Christine M. Lohse;Bradley C. Leibovich

  • Carbonic Anhydrase IX Is an Independent Predictor of Survival in Advanced Renal Clear Cell Carcinoma

    Matthew H. T. Bui;David Seligson;Ken-ryu Han;Allan J. Pantuck

  • PROSTATE CANCER DIAGNOSIS USING A SATURATION NEEDLE BIOPSY TECHNIQUE AFTER PREVIOUS NEGATIVE SEXTANT BIOPSIES

    Christopher S. Stewart;Bradley C. Leibovich;Amy L. Weaver;Michael M. Lieber

  • 618: Costimulatory B7-H1 In Renal Cell Carcinoma Patients: Indicator of Tumor Aggressiveness and Potential Therapeutic Target

    R. Houston Thompson;Michael D. Gillett;John C. Cheville;Christine M. Lohse

  • Comparative Effectiveness for Survival and Renal Function of Partial and Radical Nephrectomy for Localized Renal Tumors: A Systematic Review and Meta-Analysis

    Simon P. Kim;R. Houston Thompson;Stephen A. Boorjian;Christopher J. Weight

  • Histological Subtype is an Independent Predictor of Outcome for Patients With Renal Cell Carcinoma

    Bradley C. Leibovich;Christine M. Lohse;Paul L. Crispen;Stephen A. Boorjian

  • Survival after complete surgical resection of multiple metastases from renal cell carcinoma

    Angela L. Alt;Stephen A. Boorjian;Christine M. Lohse;Brian A. Costello

  • Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome.

    John C Cheville;Christine M Lohse;Horst Zincke;Amy L Weaver

  • B7-H4 expression in renal cell carcinoma and tumor vasculature: Associations with cancer progression and survival

    Amy E. Krambeck;R. Houston Thompson;Haidong Dong;Christine M. Lohse

  • Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses

    R. Houston Thompson;Tom Atwell;Grant Schmit;Christine M. Lohse

  • Renal Function After Partial Nephrectomy: Effect of Warm Ischemia Relative to Quantity and Quality of Preserved Kidney

    R. Houston Thompson;Brian R. Lane;Christine M. Lohse;Bradley C. Leibovich

Frequent Co-Authors

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are interested in healthcare but not set on traditional medical school, there are several related online degrees and career pathways to consider. Many students opt for a nutritionist online degree, preparing for roles that focus on health and wellness outside a clinical setting. This pathway is ideal for those passionate about preventive care and dietary health.

For those interested in healthcare leadership, exploring which online healthcare administration programs have cahme accreditation? is crucial. Accreditation ensures your degree meets industry standards and can open doors to roles in hospital or clinic management.

Nursing professionals seeking career growth can pursue the best online rn to bsn programs without clinical requirements. These flexible programs allow registered nurses to further their education on their own schedule, making it easier to balance work and study.

Those aiming for advanced practice or leadership roles can consider the shortest dnp programs online. These fast-track doctoral programs prepare graduates for high-level clinical or academic positions in less time.

Best Scientists Citing Bradley C. Leibovich

Trending Scientists

Recently Published Articles